|
Oct 10
|
Trending tickers: Tata Investment Corporation, Tesla, HSBC, GSK and BMW
|
|
Oct 10
|
FTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets £1.1bn bid
|
|
Oct 10
|
GSK shares jump after landmark £1.68bn heartburn drug settlement
|
|
Oct 10
|
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
|
|
Oct 10
|
GSK shares jump on $2.2 billion Zantac settlement
|
|
Oct 9
|
Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday
|
|
Oct 9
|
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
|
|
Oct 9
|
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
|
|
Sep 30
|
GSK plc (NYSE:GSK) Doesn’t Rank Too High In The List Of The Best Global Stocks To Buy
|
|
Sep 19
|
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
|
|
Sep 18
|
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
|
|
Sep 18
|
GSK settles two California lawsuits related to heartburn drug Zantac
|
|
Sep 18
|
GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic Alliances, and New Vaccine Launches
|
|
Sep 18
|
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
|
|
Sep 16
|
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
|
|
Sep 13
|
BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar?
|
|
Sep 13
|
Top fund picks for self-invested pensions
|
|
Sep 12
|
Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug
|
|
Sep 11
|
Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada
|
|
Aug 30
|
Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?
|